These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25632232)

  • 1. PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy.
    Byeon HJ; Kim I; Choi JS; Lee ES; Shin BS; Youn YS
    Int J Nanomedicine; 2015; 10():739-48. PubMed ID: 25632232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
    Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
    Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
    Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
    J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Kim H; Jeong D; Kang HE; Lee KC; Na K
    J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer.
    Byeon HJ; Choi SH; Choi JS; Kim I; Shin BS; Lee ES; Park ES; Lee KC; Youn YS
    Acta Biomater; 2014 Jan; 10(1):142-50. PubMed ID: 24021228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy.
    Jiang HH; Kim TH; Lee S; Chen X; Youn YS; Lee KC
    Biomaterials; 2011 Nov; 32(33):8529-37. PubMed ID: 21855130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency.
    Mok H; Park JW; Park TG
    Pharm Res; 2007 Dec; 24(12):2263-9. PubMed ID: 17929147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
    Kavas A; Keskin D; Altunbaş K; Tezcaner A
    Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres.
    Castellanos IJ; Flores G; Griebenow K
    J Pharm Pharmacol; 2005 Oct; 57(10):1261-69. PubMed ID: 16259754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
    Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
    Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
    Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
    Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC
    J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
    Hafner AM; Corthésy B; Textor M; Merkle HP
    Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of additives on the release of a model protein from PLGA microspheres.
    Kang F; Singh J
    AAPS PharmSciTech; 2001 Dec; 2(4):30. PubMed ID: 14727867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
    Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.
    Castellanos IJ; Al-Azzam W; Griebenow K
    J Pharm Sci; 2005 Feb; 94(2):327-40. PubMed ID: 15570602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis.
    Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation.
    Geng Y; Yuan W; Wu F; Chen J; He M; Jin T
    J Control Release; 2008 Sep; 130(3):259-65. PubMed ID: 18620011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.